Decreased circulating concentrations of adiponectin are associated with many obesity-related cancer diseases, including breast cancer, endometrial cancer, gastric cancer, colorectal cancer, renal cell carcinoma and prostate cancer [10], [11], [12], [13], [14], [15], [16]. Here, ADIPOQ is linked to breast carcinoma.